CD274 and neoplasm: Moreover, microsatellite stable (MS) tumours harboured DNA polymerase-ε (POLE) mutation result in ultra-high TMB and neoantigen loads that are responsive to PDL-1 monoclonal antibody (mAb) therapy [9–11].